SecBot SecBot
SC 13G ·Filed Oct 27, 2026

VNDA

Vanda Pharmaceuticals Inc.
NEUTRAL
Impact 4/10
Processed5h 6m ago SEC0002052113-26-001132
Passive investor 5%+ stake

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0002052113-26-001132
Document: Item_7.txt0002052113-26-001132
Document: 0002052113-26-001132-index-headers.html0002052113-26-001132
Document: 0002052113-26-001132-index.html0002052113-26-001132
Document: 0002052113-26-001132.txt0002052113-26-001132
5 reports for VNDA
Performance horizon
Filters
Rows
Reports for VNDA — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G
NEUTRAL ★ 4/10
$4.04awaiting T+20—$3.94 (−2.48%)
Oct 21, 2026
6d ago
Press Release
NEUTRAL ★ 1/10
$4.05awaiting T+20—$3.94 (−2.72%)
Oct 9, 2026
18d ago
SC 13G/A
NEUTRAL ★ 4/10
$4.54awaiting T+20—$3.94 (−13.22%)
Jul 29, 2026
12w ago
Press Release
NEUTRAL ★ 1/10
$5.18awaiting T+20—$3.94 (−23.94%)
May 6, 2026
24w ago
8-K
MIXED ★ 6/10
$6.39 $6.09▼ −4.69%▼ −7.83%$3.94 (−38.34%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (12h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh VNDA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access